Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Rational genomic optimization of DNA detection for human papillomavirus type 16 in head and neck squamous cell carcinoma.

Saito Y, Favorov AV, Forman M, Ren S, Sakai A, Fukusumi T, Liu C, Sadat S, Ando M, Xu G, Khan Z, Pang J, Valsamakis A, Fisch KM, Califano JA.

Head Neck. 2019 Dec 18. doi: 10.1002/hed.26041. [Epub ahead of print]

PMID:
31850594
2.

What Do Neighbors Tell About You: The Local Context of Cis-Regulatory Modules Complicates Prediction of Regulatory Variants.

Penzar DD, Zinkevich AO, Vorontsov IE, Sitnik VV, Favorov AV, Makeev VJ, Kulakovskiy IV.

Front Genet. 2019 Oct 31;10:1078. doi: 10.3389/fgene.2019.01078. eCollection 2019.

3.

Allele-specific nonstationarity in evolution of influenza A virus surface proteins.

Popova AV, Safina KR, Ptushenko VV, Stolyarova AV, Favorov AV, Neverov AD, Bazykin GA.

Proc Natl Acad Sci U S A. 2019 Oct 15;116(42):21104-21112. doi: 10.1073/pnas.1904246116. Epub 2019 Oct 2.

PMID:
31578251
4.

Differential Variation Analysis Enables Detection of Tumor Heterogeneity Using Single-Cell RNA-Sequencing Data.

Davis-Marcisak EF, Sherman TD, Orugunta P, Stein-O'Brien GL, Puram SV, Roussos Torres ET, Hopkins AC, Jaffee EM, Favorov AV, Afsari B, Goff LA, Fertig EJ.

Cancer Res. 2019 Oct 1;79(19):5102-5112. doi: 10.1158/0008-5472.CAN-18-3882. Epub 2019 Jul 23.

PMID:
31337651
5.

Publisher Correction: Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.

Ando M, Saito Y, Xu G, Bui NQ, Medetgul-Ernar K, Pu M, Fisch K, Ren S, Sakai A, Fukusumi T, Liu C, Haft S, Pang J, Mark A, Gaykalova DA, Guo T, Favorov AV, Yegnasubramanian S, Fertig EJ, Ha P, Tamayo P, Yamasoba T, Ideker T, Messer K, Califano JA.

Nat Commun. 2019 May 29;10(1):2415. doi: 10.1038/s41467-019-10557-7.

6.

Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.

Ando M, Saito Y, Xu G, Bui NQ, Medetgul-Ernar K, Pu M, Fisch K, Ren S, Sakai A, Fukusumi T, Liu C, Haft S, Pang J, Mark A, Gaykalova DA, Guo T, Favorov AV, Yegnasubramanian S, Fertig EJ, Ha P, Tamayo P, Yamasoba T, Ideker T, Messer K, Califano JA.

Nat Commun. 2019 May 16;10(1):2188. doi: 10.1038/s41467-019-09937-w. Erratum in: Nat Commun. 2019 May 29;10(1):2415.

7.

Enter the Matrix: Factorization Uncovers Knowledge from Omics.

Stein-O'Brien GL, Arora R, Culhane AC, Favorov AV, Garmire LX, Greene CS, Goff LA, Li Y, Ngom A, Ochs MF, Xu Y, Fertig EJ.

Trends Genet. 2018 Oct;34(10):790-805. doi: 10.1016/j.tig.2018.07.003. Epub 2018 Aug 22. Review.

8.

Functional characterization of alternatively spliced GSN in head and neck squamous cell carcinoma.

Kelley DZ, Flam EL, Guo T, Danilova LV, Zamuner FT, Bohrson C, Considine M, Windsor EJ, Bishop JA, Zhang C, Koch WM, Sidransky D, Westra WH, Chung CH, Califano JA, Wheelan S, Favorov AV, Florea L, Fertig EJ, Gaykalova DA.

Transl Res. 2018 Dec;202:109-119. doi: 10.1016/j.trsl.2018.07.007. Epub 2018 Jul 26.

9.

Integrated time course omics analysis distinguishes immediate therapeutic response from acquired resistance.

Stein-O'Brien G, Kagohara LT, Li S, Thakar M, Ranaweera R, Ozawa H, Cheng H, Considine M, Schmitz S, Favorov AV, Danilova LV, Califano JA, Izumchenko E, Gaykalova DA, Chung CH, Fertig EJ.

Genome Med. 2018 May 23;10(1):37. doi: 10.1186/s13073-018-0545-2.

10.

Splice Expression Variation Analysis (SEVA) for inter-tumor heterogeneity of gene isoform usage in cancer.

Afsari B, Guo T, Considine M, Florea L, Kagohara LT, Stein-O'Brien GL, Kelley D, Flam E, Zambo KD, Ha PK, Geman D, Ochs MF, Califano JA, Gaykalova DA, Favorov AV, Fertig EJ.

Bioinformatics. 2018 Jun 1;34(11):1859-1867. doi: 10.1093/bioinformatics/bty004.

11.

Multilocus Analysis of Genetic Susceptibility to Myocardial Infarction in Russians: Replication Study.

Kukava NG, Titov BV, Osmak GJ, Matveeva NA, Kulakova OG, Favorov AV, Shakhnovich RM, Ruda MY, Favorova OO.

Acta Naturae. 2017 Oct-Dec;9(4):74-83.

12.

DNA methylation regulates TMEM16A/ANO1 expression through multiple CpG islands in head and neck squamous cell carcinoma.

Finegersh A, Kulich S, Guo T, Favorov AV, Fertig EJ, Danilova LV, Gaykalova DA, Califano JA, Duvvuri U.

Sci Rep. 2017 Nov 9;7(1):15173. doi: 10.1038/s41598-017-15634-9.

13.

StereoGene: rapid estimation of genome-wide correlation of continuous or interval feature data.

Stavrovskaya ED, Niranjan T, Fertig EJ, Wheelan SJ, Favorov AV, Mironov AA.

Bioinformatics. 2017 Oct 15;33(20):3158-3165. doi: 10.1093/bioinformatics/btx379.

14.

Epigenetic regulation of gene expression in cancer: techniques, resources and analysis.

Kagohara LT, Stein-O'Brien GL, Kelley D, Flam E, Wick HC, Danilova LV, Easwaran H, Favorov AV, Qian J, Gaykalova DA, Fertig EJ.

Brief Funct Genomics. 2018 Jan 1;17(1):49-63. doi: 10.1093/bfgp/elx018.

15.

VirGenA: a reference-based assembler for variable viral genomes.

Fedonin GG, Fantin YS, Favorov AV, Shipulin GA, Neverov AD.

Brief Bioinform. 2019 Jan 18;20(1):15-25. doi: 10.1093/bib/bbx079.

16.

Integrated Analysis of Whole-Genome ChIP-Seq and RNA-Seq Data of Primary Head and Neck Tumor Samples Associates HPV Integration Sites with Open Chromatin Marks.

Kelley DZ, Flam EL, Izumchenko E, Danilova LV, Wulf HA, Guo T, Singman DA, Afsari B, Skaist AM, Considine M, Welch JA, Stavrovskaya E, Bishop JA, Westra WH, Khan Z, Koch WM, Sidransky D, Wheelan SJ, Califano JA, Favorov AV, Fertig EJ, Gaykalova DA.

Cancer Res. 2017 Dec 1;77(23):6538-6550. doi: 10.1158/0008-5472.CAN-17-0833. Epub 2017 Sep 25.

17.

A Novel Functional Splice Variant of AKT3 Defined by Analysis of Alternative Splice Expression in HPV-Positive Oropharyngeal Cancers.

Guo T, Sakai A, Afsari B, Considine M, Danilova L, Favorov AV, Yegnasubramanian S, Kelley DZ, Flam E, Ha PK, Khan Z, Wheelan SJ, Gutkind JS, Fertig EJ, Gaykalova DA, Califano J.

Cancer Res. 2017 Oct 1;77(19):5248-5258. doi: 10.1158/0008-5472.CAN-16-3106. Epub 2017 Jul 21.

18.

Genetic risk factors for myocardial infarction more clearly manifest for early age of first onset.

Titov BV, Osmak GJ, Matveeva NA, Kukava NG, Shakhnovich RM, Favorov AV, Ruda MY, Favorova OO.

Mol Biol Rep. 2017 Aug;44(4):315-321. doi: 10.1007/s11033-017-4112-5. Epub 2017 Jul 6.

PMID:
28685248
19.

PatternMarkers & GWCoGAPS for novel data-driven biomarkers via whole transcriptome NMF.

Stein-O'Brien GL, Carey JL, Lee WS, Considine M, Favorov AV, Flam E, Guo T, Li S, Marchionni L, Sherman T, Sivy S, Gaykalova DA, McKay RD, Ochs MF, Colantuoni C, Fertig EJ.

Bioinformatics. 2017 Jun 15;33(12):1892-1894. doi: 10.1093/bioinformatics/btx058.

20.

Whole-Genome DNA Methylation Analysis of Peripheral Blood Mononuclear Cells in Multiple Sclerosis Patients with Different Disease Courses.

Kulakova OG, Kabilov MR, Danilova LV, Popova EV, Baturina OA, Tsareva EY, Baulina NM, Kiselev IS, Boyko AN, Favorov AV, Favorova OO, Vlassov VV.

Acta Naturae. 2016 Jul-Sep;8(3):103-110.

21.

CoGAPS matrix factorization algorithm identifies transcriptional changes in AP-2alpha target genes in feedback from therapeutic inhibition of the EGFR network.

Fertig EJ, Ozawa H, Thakar M, Howard JD, Kagohara LT, Krigsfeld G, Ranaweera RS, Hughes RM, Perez J, Jones S, Favorov AV, Carey J, Stein-O'Brien G, Gaykalova DA, Ochs MF, Chung CH.

Oncotarget. 2016 Nov 8;7(45):73845-73864. doi: 10.18632/oncotarget.12075.

22.

Inferring causal molecular networks: empirical assessment through a community-based effort.

Hill SM, Heiser LM, Cokelaer T, Unger M, Nesser NK, Carlin DE, Zhang Y, Sokolov A, Paull EO, Wong CK, Graim K, Bivol A, Wang H, Zhu F, Afsari B, Danilova LV, Favorov AV, Lee WS, Taylor D, Hu CW, Long BL, Noren DP, Bisberg AJ; HPN-DREAM Consortium, Mills GB, Gray JW, Kellen M, Norman T, Friend S, Qutub AA, Fertig EJ, Guan Y, Song M, Stuart JM, Spellman PT, Koeppl H, Stolovitzky G, Saez-Rodriguez J, Mukherjee S.

Nat Methods. 2016 Apr;13(4):310-8. doi: 10.1038/nmeth.3773. Epub 2016 Feb 22.

23.

Variants of the Coagulation and Inflammation Genes Are Replicably Associated with Myocardial Infarction and Epistatically Interact in Russians.

Barsova RM, Lvovs D, Titov BV, Matveeva NA, Shakhnovich RM, Sukhinina TS, Kukava NG, Ruda MY, Karamova IM, Nasibullin TR, Mustafina OE, Osmak GJ, Tsareva EY, Kulakova OG, Favorov AV, Favorova OO.

PLoS One. 2015 Dec 10;10(12):e0144190. doi: 10.1371/journal.pone.0144190. eCollection 2015.

24.

A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches.

Bashinskaya VV, Kulakova OG, Boyko AN, Favorov AV, Favorova OO.

Hum Genet. 2015 Nov;134(11-12):1143-62. doi: 10.1007/s00439-015-1601-2. Epub 2015 Sep 25. Review.

PMID:
26407970
25.

GWAS-identified multiple sclerosis risk loci involved in immune response: validation in Russians.

Bashinskaya VV, Kulakova OG, Kiselev IS, Baulina NM, Favorov AV, Boyko AN, Tsareva EY, Favorova OO.

J Neuroimmunol. 2015 May 15;282:85-91. doi: 10.1016/j.jneuroim.2015.03.015. Epub 2015 Mar 17.

PMID:
25903733
26.

Natural variation of gene models in Drosophila melanogaster.

Kurmangaliyev YZ, Favorov AV, Osman NM, Lehmann KV, Campo D, Salomon MP, Tower J, Gelfand MS, Nuzhdin SV.

BMC Genomics. 2015 Mar 17;16:198. doi: 10.1186/s12864-015-1415-6.

27.

[Genome-wide association study as a method for genetic architecture analysis in polygenic diseases (by the example of multiple sclerosis)].

Favorova OO, Bashinskaia VV, Kulakova OG, Favorov AV, Boĭko AN.

Mol Biol (Mosk). 2014 Jul-Aug;48(4):573-86. Review. Russian.

28.

Weak negative and positive selection and the drift load at splice sites.

Denisov SV, Bazykin GA, Sutormin R, Favorov AV, Mironov AA, Gelfand MS, Kondrashov AS.

Genome Biol Evol. 2014 May 14;6(6):1437-47. doi: 10.1093/gbe/evu100.

29.

Preserving biological heterogeneity with a permuted surrogate variable analysis for genomics batch correction.

Parker HS, Leek JT, Favorov AV, Considine M, Xia X, Chavan S, Chung CH, Fertig EJ.

Bioinformatics. 2014 Oct;30(19):2757-63. doi: 10.1093/bioinformatics/btu375. Epub 2014 Jun 6.

30.

Comparative pharmacogenetics of multiple sclerosis: IFN-β versus glatiramer acetate.

Kulakova OG, Tsareva EY, Lvovs D, Favorov AV, Boyko AN, Favorova OO.

Pharmacogenomics. 2014 Apr;15(5):679-85. doi: 10.2217/pgs.14.26.

PMID:
24798724
31.

A promoter-level mammalian expression atlas.

FANTOM Consortium and the RIKEN PMI and CLST (DGT), Forrest AR, Kawaji H, Rehli M, Baillie JK, de Hoon MJ, Haberle V, Lassmann T, Kulakovskiy IV, Lizio M, Itoh M, Andersson R, Mungall CJ, Meehan TF, Schmeier S, Bertin N, Jørgensen M, Dimont E, Arner E, Schmidl C, Schaefer U, Medvedeva YA, Plessy C, Vitezic M, Severin J, Semple C, Ishizu Y, Young RS, Francescatto M, Alam I, Albanese D, Altschuler GM, Arakawa T, Archer JA, Arner P, Babina M, Rennie S, Balwierz PJ, Beckhouse AG, Pradhan-Bhatt S, Blake JA, Blumenthal A, Bodega B, Bonetti A, Briggs J, Brombacher F, Burroughs AM, Califano A, Cannistraci CV, Carbajo D, Chen Y, Chierici M, Ciani Y, Clevers HC, Dalla E, Davis CA, Detmar M, Diehl AD, Dohi T, Drabløs F, Edge AS, Edinger M, Ekwall K, Endoh M, Enomoto H, Fagiolini M, Fairbairn L, Fang H, Farach-Carson MC, Faulkner GJ, Favorov AV, Fisher ME, Frith MC, Fujita R, Fukuda S, Furlanello C, Furino M, Furusawa J, Geijtenbeek TB, Gibson AP, Gingeras T, Goldowitz D, Gough J, Guhl S, Guler R, Gustincich S, Ha TJ, Hamaguchi M, Hara M, Harbers M, Harshbarger J, Hasegawa A, Hasegawa Y, Hashimoto T, Herlyn M, Hitchens KJ, Ho Sui SJ, Hofmann OM, Hoof I, Hori F, Huminiecki L, Iida K, Ikawa T, Jankovic BR, Jia H, Joshi A, Jurman G, Kaczkowski B, Kai C, Kaida K, Kaiho A, Kajiyama K, Kanamori-Katayama M, Kasianov AS, Kasukawa T, Katayama S, Kato S, Kawaguchi S, Kawamoto H, Kawamura YI, Kawashima T, Kempfle JS, Kenna TJ, Kere J, Khachigian LM, Kitamura T, Klinken SP, Knox AJ, Kojima M, Kojima S, Kondo N, Koseki H, Koyasu S, Krampitz S, Kubosaki A, Kwon AT, Laros JF, Lee W, Lennartsson A, Li K, Lilje B, Lipovich L, Mackay-Sim A, Manabe R, Mar JC, Marchand B, Mathelier A, Mejhert N, Meynert A, Mizuno Y, de Lima Morais DA, Morikawa H, Morimoto M, Moro K, Motakis E, Motohashi H, Mummery CL, Murata M, Nagao-Sato S, Nakachi Y, Nakahara F, Nakamura T, Nakamura Y, Nakazato K, van Nimwegen E, Ninomiya N, Nishiyori H, Noma S, Noma S, Noazaki T, Ogishima S, Ohkura N, Ohimiya H, Ohno H, Ohshima M, Okada-Hatakeyama M, Okazaki Y, Orlando V, Ovchinnikov DA, Pain A, Passier R, Patrikakis M, Persson H, Piazza S, Prendergast JG, Rackham OJ, Ramilowski JA, Rashid M, Ravasi T, Rizzu P, Roncador M, Roy S, Rye MB, Saijyo E, Sajantila A, Saka A, Sakaguchi S, Sakai M, Sato H, Savvi S, Saxena A, Schneider C, Schultes EA, Schulze-Tanzil GG, Schwegmann A, Sengstag T, Sheng G, Shimoji H, Shimoni Y, Shin JW, Simon C, Sugiyama D, Sugiyama T, Suzuki M, Suzuki N, Swoboda RK, 't Hoen PA, Tagami M, Takahashi N, Takai J, Tanaka H, Tatsukawa H, Tatum Z, Thompson M, Toyodo H, Toyoda T, Valen E, van de Wetering M, van den Berg LM, Verado R, Vijayan D, Vorontsov IE, Wasserman WW, Watanabe S, Wells CA, Winteringham LN, Wolvetang E, Wood EJ, Yamaguchi Y, Yamamoto M, Yoneda M, Yonekura Y, Yoshida S, Zabierowski SE, Zhang PG, Zhao X, Zucchelli S, Summers KM, Suzuki H, Daub CO, Kawai J, Heutink P, Hide W, Freeman TC, Lenhard B, Bajic VB, Taylor MS, Makeev VJ, Sandelin A, Hume DA, Carninci P, Hayashizaki Y.

Nature. 2014 Mar 27;507(7493):462-70. doi: 10.1038/nature13182.

32.

[The activation of the type I interferon signaling pathway in multiple sclerosis patients treated with russian analogue of Β-interferon-1b: transcriptome profiling data].

Danilova LV, Popova EV, Kulakova OG, Tsareva EIu, Favorov AV, Favorova OO, Boĭko AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(2 Pt 2):72-7. Russian.

PMID:
24662360
33.

Heavy-light chain interrelations of MS-associated immunoglobulins probed by deep sequencing and rational variation.

Lomakin YA, Zakharova MY, Stepanov AV, Dronina MA, Smirnov IV, Bobik TV, Pyrkov AY, Tikunova NV, Sharanova SN, Boitsov VM, Vyazmin SY, Kabilov MR, Tupikin AE, Krasnov AN, Bykova NA, Medvedeva YA, Fridman MV, Favorov AV, Ponomarenko NA, Dubina MV, Boyko AN, Vlassov VV, Belogurov AA Jr, Gabibov AG.

Mol Immunol. 2014 Dec;62(2):305-14. doi: 10.1016/j.molimm.2014.01.013. Epub 2014 Feb 16.

34.

Polyreactive monoclonal autoantibodies in multiple sclerosis: functional selection from phage display library and characterization by deep sequencing analysis.

Lomakin YA, Zakharova MY, Belogurov AA, Bykova NA, Dronina MA, Tupikin AE, Knorre VD, Boyko AN, Favorov AV, Kabilov MR, Ponomarenko NA, Gabibov G.

Acta Naturae. 2013 Oct;5(4):94-104.

35.

Hidden Markov models for evolution and comparative genomics analysis.

Bykova NA, Favorov AV, Mironov AA.

PLoS One. 2013 Jun 7;8(6):e65012. doi: 10.1371/journal.pone.0065012. Print 2013.

36.

Identifying context-specific transcription factor targets from prior knowledge and gene expression data.

Fertig EJ, Favorov AV, Ochs MF.

IEEE Trans Nanobioscience. 2013 Sep;12(3):142-9. doi: 10.1109/TNB.2013.2263390. Epub 2013 May 16.

37.

Base-calling algorithm with vocabulary (BCV) method for analyzing population sequencing chromatograms.

Fantin YS, Neverov AD, Favorov AV, Alvarez-Figueroa MV, Braslavskaya SI, Gordukova MA, Karandashova IV, Kuleshov KV, Myznikova AI, Polishchuk MS, Reshetov DA, Voiciehovskaya YA, Mironov AA, Chulanov VP.

PLoS One. 2013;8(1):e54835. doi: 10.1371/journal.pone.0054835. Epub 2013 Jan 28.

38.

Allelic combinations of immune-response genes as possible composite markers of IFN-β efficacy in multiple sclerosis patients.

Kulakova OG, Tsareva EY, Boyko AN, Shchur SG, Gusev EI, Lvovs D, Favorov AV, Vandenbroeck K, Favorova OO.

Pharmacogenomics. 2012 Nov;13(15):1689-700. doi: 10.2217/pgs.12.161.

PMID:
23171334
39.

A Polygenic Approach to the Study 
of Polygenic Diseases.

Lvovs D, Favorova OO, Favorov AV.

Acta Naturae. 2012 Jul;4(3):59-71.

40.

Contribution of the TGFB1 Gene 
to Myocardial Infarction Susceptibility.

Barsova RM, Titov BV, Matveeva NA, Favorov AV, Sukhinina TS, Shahnovich RM, Ruda MIa, Favorova OO.

Acta Naturae. 2012 Apr;4(2):74-9.

41.

[Polymorphic variants of genes encoding interleukin-6 and fibrinogen, the risk of ischemic stroke and fibrinogen levels].

Titov BV, Barsova RM, Martynov MIu, Nikonova AA, Favorov AV, Gusev EI, Favorova OO.

Mol Biol (Mosk). 2012 Jan-Feb;46(1):93-102. Russian.

PMID:
22642105
42.

[Correlations between clusters of protein-DNA binding sites and the binding experimental data allow to predict a structure of regulatory modules].

Nikulova AA, Polishchuk MS, Tumanian VG, Makeev VIu, Mironov AA, Favorov AV.

Biofizika. 2012 Mar-Apr;57(2):212-4. Russian.

PMID:
22594275
43.

CORECLUST: identification of the conserved CRM grammar together with prediction of gene regulation.

Nikulova AA, Favorov AV, Sutormin RA, Makeev VJ, Mironov AA.

Nucleic Acids Res. 2012 Jul;40(12):e93. doi: 10.1093/nar/gks235. Epub 2012 Mar 15.

44.

Hybrid Modeling of Cell Signaling and Transcriptional Reprogramming and Its Application in C. elegans Development.

Fertig EJ, Danilova LV, Favorov AV, Ochs MF.

Front Genet. 2011 Nov 8;2:77. doi: 10.3389/fgene.2011.00077. eCollection 2011.

45.

[Pharmacogenomics of multiple sclerosis: association of immune response genes polymorphism with copaxone treatment efficacy].

Tsareva EIu, Kulakova OG, Makarycheva OIu, Boĭko AN, Shchur SG, Lashch NIu, Popova NF, Gusev EI, Bashinskaia VV, L'vov DV, Favorov AV, Ochs MF, Favorova OO.

Mol Biol (Mosk). 2011 Nov-Dec;45(6):963-72. Russian.

PMID:
22295566
46.

[Splice sites are overrepresented in Pasilla binding motif clusters in D. melanogaster genes].

Polishchuk MS, Brown JB, Favorov AV, Bickel PJ, Tumanian VG.

Biofizika. 2011 Nov-Dec;56(6):1065-70. Russian.

PMID:
22279750
47.

Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients.

Tsareva EY, Kulakova OG, Boyko AN, Shchur SG, Lvovs D, Favorov AV, Gusev EI, Vandenbroeck K, Favorova OO.

Pharmacogenomics. 2012 Jan;13(1):43-53. doi: 10.2217/pgs.11.136. Epub 2011 Nov 23.

PMID:
22111603
48.
49.

CoGAPS: an R/C++ package to identify patterns and biological process activity in transcriptomic data.

Fertig EJ, Ding J, Favorov AV, Parmigiani G, Ochs MF.

Bioinformatics. 2010 Nov 1;26(21):2792-3. doi: 10.1093/bioinformatics/btq503. Epub 2010 Sep 1.

50.

Deep and wide digging for binding motifs in ChIP-Seq data.

Kulakovskiy IV, Boeva VA, Favorov AV, Makeev VJ.

Bioinformatics. 2010 Oct 15;26(20):2622-3. doi: 10.1093/bioinformatics/btq488. Epub 2010 Aug 24.

PMID:
20736340

Supplemental Content

Loading ...
Support Center